+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 75Years
All Genders
Healthy Volunteers
ID07615023

Study of Clonal Hematopoiesis and Heart Damage Severity in Patients with ST-Elevation Myocardial Infarction

Led by Medical University Innsbruck · Updated on 2026-10-09

350

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating the link between Clonal Hematopoiesis of Indeterminate Potential CHIP and heart damage severity in patients who have suffered ST-elevation myocardial infarction STEMI, a severe type of heart attack. CHIP involves the growth of blood stem cell clones with certain mutations, which may increase inflammation and cardiovascular risks like heart attacks and strokes. This observational study aims to see if CHIP is connected to worse heart injury and outcomes after STEMI treated by primary percutaneous coronary intervention PCI. Participants will undergo blood tests to detect CHIP mutations using targeted next-generation sequencing and will receive cardiac magnetic resonance imaging MRI about 5 days after PCI to assess heart damage including microvascular obstruction, intramyocardial hemorrhage, and infarct size. Additional blood tests will monitor inflammation and heart stress markers, and immune cell gene activity will be analyzed at baseline and after 12 months. No experimental treatments are given all patients receive standard care for STEMI. During the study, participants will have clinical follow-ups at 12, 24, and 48 months to track major cardiovascular events like death, reinfarction, or heart failure hospitalization. Researchers will measure heart function and injury through MRI and blood biomarkers, and analyze CHIP mutation changes over time. The study will enroll 350 STEMI patients aged 18 to 75 years and follow them for four years to better understand how CHIP influences heart attack recovery and risks.

CONDITIONS

Brief Title

Clonal Hematopoiesis of Indeterminate Potential and Infarct Severity in ST-Elevation Myocardial Infarction

Research Team

I

Ivan Lechner, MD, PhD

S

Sebastian J Reinstadler, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here